Honored, excited, and incredibly grateful to have contributed to 3 presentations at #ASCO26 this year!
🏅 ASCO AYA Featured Poster on multimodal risk phenotyping in early-onset colorectal cancer
📈 Poster on leadership attainment among participants in the ASCO Leadership Development Program
🎤 Rapid Oral Presentation on gender representation in first and senior authorship of phase III solid tumor trials
A special congratulations to my mentor @Sarbaji85064063 on being selected for the Leadership Development Program. Thank you @BrainTumorDoc @ZouinaS @QidwaiKhalid@nihanakkoc@BaptistHealthSF for your support!
#ASCO26 #CancerResearch #Oncology #meded #gender #AYA
Honored, excited, and incredibly grateful to have contributed to 3 presentations at #ASCO26 this year!
🏅 ASCO AYA Featured Poster on multimodal risk phenotyping in early-onset colorectal cancer
📈 Poster on leadership attainment among participants in the ASCO Leadership Development Program
🎤 Rapid Oral Presentation on gender representation in first and senior authorship of phase III solid tumor trials
A special congratulations to my mentor @Sarbaji85064063 on being selected for the Leadership Development Program. Thank you @BrainTumorDoc @ZouinaS @QidwaiKhalid@nihanakkoc@BaptistHealthSF for your support!
#ASCO26 #CancerResearch #Oncology #meded #gender #AYA
🎯 What predicts leadership attainment in oncology?
Congrats to Sarah Abraham on presenting this ASCO 2026 poster on outcomes among @ASCO Leadership Development Program graduates. The study highlights associations between leadership attainment, scholarly productivity, and geographic region.
As a current #ASCOLDP participant, I found these findings especially meaningful
Remarkable achievement for Sarah to present an ASCO poster as a medical student!
@AzzaSarfraz @ZouinaS @nihanakkoc@BrainTumorDoc@BaptistHealthSF@MiamiCancerInst@FIU
#ASCO2026 #OncologyLeadership #LeadershipDevelopment
Honored to contribute to this work and excited to see it presented at #ASCO2026. Grateful to Dr. Mukherjee, our collaborators, and the outstanding team at Miami Cancer Institute for the opportunity. Looking forward to a great meeting and the research ahead.
🚀 ASCO 2026 is officially underway!
Excited to kick off the meeting by presenting our study on authorship trends in Phase III solid tumor clinical trials presented at #ASCO from 2015–2025.
Grateful to @ASCO for selecting our work and to @AzzaSarfraz and our medical students at @FIU for their incredible contributions that made this project possible.
And this is just Day 1.
Our GI Cancer team at @BaptistHealthSF@MiamiCancerInst will be presenting multiple posters and research updates throughout the meeting. More to come—stay tuned!
@BrainTumorDoc@BrunaPellini @ZouinaS @sawyer_bawek@nihanakkoc
#ASCO2026 #Oncology #CancerResearch #ClinicalTrials #GICancer
How do we close the gap between promising clinical trial data and real-world patient care?
Looking forward to joining an outstanding group of colleagues at the Frontiers Meets Frontlines satellite event during #ASCO2026 to discuss emerging advances in GI oncology and their practical application in the clinic.
Thanks to @TotalHealthConf , @Onco_Nexus, and @GIMedOnc for the invitation.
Honored to share the panel with:
@YJanjigianMD@marklewismd
If you’re attending ASCO, please join us in person or virtually for what should be a highly engaging discussion.
@BaptistHealthSF @BHCancerCare @MiamiCancerInst
#GIOncology #ClinicalTrials #ASCO
🚨 New publication!
In 38,000+ patients nationwide, we show that pregnancy meaningfully alters cancer treatment pathways and impacts maternal and neonatal outcomes 🤰📊
Proud of this collaborative work with @timpawlik and @OhioStateSurg.
🔗 https://t.co/Ljwara9ibb
#SurgOnc #WomensHealth #Oncology
Outstanding and highly informative talk by Dr. @Sarbaji85064063 on ADCs in GI cancers, covering target expression patterns, biologic and trial design challenges, and next-generation strategies. A masterclass on where the field is headed. A truly insightful session!
@MiamiCancerInst@BrainTumorDoc@oncodaily@OncoAlert #MCIPrecisionOncology
New @CellCellPress
The hallmarks of cancer, refined from the original concepts 25 years ago, as an outgrowth of our expanding knowledge base
https://t.co/kjAYDRxvKD
Such an insightful and informative session! So glad I had the opportunity to meet you, Dr. @VivekSubbiah. Thank you for the inspiring discussion on precision oncology. @ZouinaS@BrainTumorDoc
⭐️Such a delight to deliver the keynote on “Re-imagining the Precision Oncology Paradigm” 👉🏼 discussing the paper published in @AACR@CD_AACR “Rethinking Cancer Drug Development through Tumor-agnostic Precision Medicine��! Fantastic Friday morning with an amazing panel discussion session & terrific colleagues @BrainTumorDoc @chadinabhan @neerajaiims @OncoAlert @oncodaily @MiamiCancerInst
https://t.co/FfPIxwSKNG
Thrilled to present our meta-analysis on immune checkpoint inhibitors in gastroenteropancreatic neuroendocrine tumors at #ASCOGI!
Pooled data show modest ORR but meaningful disease stabilization, highlighting the need for biomarker-driven strategies.
Grateful to my incredible co-authors and @ZouinaS @Sarbaji85064063@Deebacca@BrainTumorDoc@nihanakkoc@MiamiCancerInst@BaptistHealthSF
#GEPNETs #OncologyResearch #ASCO #GI26
Very excited to join @MiamiCancerInst at @BaptistHealthSF@BHCancerCare as part of the GI Oncology Research Team! Looking forward to building impactful, patient-centered research in precision oncology and global collaboration. Grateful to @Sarbaji85064063 for the mentorship!
Thrilled to welcome @AzzaSarfraz to the GI Oncology Research Team at @MiamiCancerInst@BaptistHealthSF @BHCancerCare
A physician-scientist from @AKUGlobal joining us from @OhioState, where she focused on GI cancer research.
Author of 150+ peer-reviewed publications (h-index 25), she brings exceptional expertise in clinical research.
We’re excited to have her on board as we expand our efforts in precision oncology, evidence generation, and global collaboration.
What a week at #CSA2025! Honored to present our work under @timpawlik and rep @OhioStateSurg. Fired up by the groundbreaking science, sharp discussions, and new connections. Let’s keep pushing forward! #Surgery
@Grammarly I was charged $144 for a yearly subscription I didn’t authorize or use. I cannot afford this. I didn’t receive any notification or confirmation about this charge. Please help me process a refund ASAP. #CustomerSupport#Urgent